India Market Recap
Indian equity benchmarks ended the special Muhurat trading session in negative territory, snapping a nine-year winning streak as early gains faded towards the close. The BSE Sensex declined 28.62 points, or 0.04%, to settle at 80,999.40, while the NSE Nifty 50 slipped 43.95 points, or 0.18%, to close at 24,986.40. Despite the muted Muhurat session, Indian markets had extended their rally for the seventh consecutive trading session on Friday, supported by buying in Private Banking and Pharma stocks, even as global equities witnessed heavy selling pressure. On the technical front, Nifty support is placed around 24,775–24,850, while resistance is seen in the 25,200–25,300 range.
US Market Recap
US equity futures edged higher on Sunday evening as investors assessed whether technology stocks could sustain their recent recovery. Market participants remained focused on the upcoming release of key inflation data and earnings announcements from major artificial intelligence companies, which could influence near-term market direction. S&P 500 futures gained 0.10%, while Nasdaq-100 futures advanced 0.30%. Futures linked to the Dow Jones Industrial Average rose 101 points, or 0.20%. Investors will closely monitor corporate earnings and inflation indicators for signals on market valuations, technology-sector growth and the broader economic outlook.
Asian Market Update
Asian equity markets opened on a mixed note on Monday, November 9, with Japanese stocks advancing while South Korean and Australian markets traded lower. Japan's Nikkei 225 gained 1.44%, while the broader Topix rose 2.09%. In contrast, South Korea's Kospi declined 0.69%, and the small-cap Kosdaq slipped 0.87%. Australia's S&P/ASX 200 fell 0.31%, reversing its initial gains. Regional markets reflected mixed global cues as investors continued to assess the outlook for technology stocks and upcoming economic developments.
Commodity Check
Crude oil prices extended their decline on Monday, with Brent crude falling below $98 per barrel after recording its steepest weekly loss since April 2020. West Texas Intermediate (WTI) crude traded near $90 per barrel. Oil prices have retreated from a six-month high recorded towards the end of October, amid changing expectations surrounding the US–Iran conflict. Market participants are assessing mixed signals from Washington regarding efforts to bring the conflict to an end. While the outcome of the US midterm elections has raised expectations that geopolitical tensions may not escalate significantly, fresh attacks in the Middle East continue to keep concerns over supply disruptions in focus. Brent crude declined more than 16% last week, reflecting a significant reduction in the geopolitical risk premium.
Stocks In News
- JTL Industries: Completes the hot trial of its Pickling Line and commences cold trials of the GP Line at its Mangaon, Maharashtra facility.
- Neogen Chemicals: Gujarat Pollution Control Board revokes its earlier closure direction related to the March 2025 Dahej SEZ fire incident, providing regulatory relief to the company.
- Deccan Gold Mines: Subsidiary signs a gold refining and sales agreement with Kyrgyzaltyn for gold doré from the Altyn Tor Gold Project. The first 1.2 kg consignment has been dispatched.
- Adani Enterprises: AdaniConneX completes the acquisition of 100% stake in Vizag Mega Data Center Park (VMDCPL), which will now operate as a joint venture of the company.
- M&M: Approves raising up to Rs. 1,500 crore through a rights issue in SML Mahindra. Rs. 855 crore is committed towards its rights entitlement, with an additional investment of up to Rs. 595 crore under consideration.
- Dabur: Receives an administrative warning letter from SEBI regarding delayed disclosure of a US FDA warning letter. The company expects no impact on its financial operations.
- Thyrocare Technologies: Preet Kaur resigns as Chief Scientific Officer.
- Shreeji Shipping Global: Board meeting scheduled for November 14 to consider a stock split.
- Tilaknagar Industries: Directorate of Revenue Intelligence (DRI) seizes imported goods worth Rs. 30.14 crore as part of a customs investigation.
- Oil India: Fire at its Tengakhat facility in Assam results in one worker's death and injuries to six others. The company deploys 11 fire tenders and constitutes an inquiry committee.
- Voltas: Noel Tata retires as Chairman effective November 11. Sunil Alaric D'Souza will take over as Chairman from November 12, while Mukundan Menon will complete his tenure as MD on May 24, 2027.
- Aarti Drugs: US FDA issues three Form 483 observations following an inspection of its Baddi facility conducted from November 2–6, 2026.
- KRBL: Delhi High Court issues notice in an award-enforcement case and seeks an affidavit disclosing the company's assets and bank-account details. The matter is scheduled for February 12, 2027.
- JSW Energy: Adds 1,784 MW of generation capacity since April, taking total installed capacity to 15,237 MW. Targets 30 GW generation capacity and 40 GWh energy storage by 2030.
- Marico: Acquires an additional 20% stake in Cosmix Wellness for Rs. 114 crore, increasing ownership to 80%. Also plans to acquire a 51% stake in Bonorizon Consumer Ventures for Rs. 35 crore.
- Sagar Cements: Receives observation letters without adverse observations from BSE and no-objection from NSE for the amalgamation of Andhra Cements with the company.
- Zaggle Prepaid: Appoints Samar Vijay Pupala as CFO. Venkatesh Ramachandran resigns as Group CFO and takes charge as Group Chief Strategy and Transformation Officer.
- Birlasoft: Angan Guha resigns as CEO and MD effective December 7. Madhavan Hariharan will take over from December 8.
- Zee Entertainment: Board meeting scheduled for November 12 to consider a share buyback and interim dividend.
- Raymond: Receives in-principle approval from stock exchanges for preferential issuance of 33 lakh convertible warrants.
- Share India: Approves the merger of Ace Alpha Tech with the company.
- GE Shipping: Takes delivery of its secondhand Very Large Gas Carrier (VLGC), Jag Vikrant, built in 2015.
- Zydus Lifesciences: Presents Phase 2b clinical data for saroglitazar at AASLD 2026. The study demonstrates greater resolution of steatohepatitis without worsening fibrosis in adults with MASH and fibrosis compared with placebo.
- Wipro: Appoints Angan Guha as CEO of Americas 2 Strategic Market Unit, effective December 8.
- One Point One Solutions: Promoter acquires 3.7 lakh shares through an open-market purchase.
- Annu Projects: Signs an MoU with Geie Solar Products for supplying materials for 8,000 rooftop solar systems.
- Aster DM Healthcare: Converts a Rs. 102.5 crore loan into equity in subsidiary Sri Sainatha through the issuance of 10.25 crore shares. Also terminates its O&M agreement and medical-services pact with DMERF.
- Equitas Small Finance Bank: Receives RBI approval for Balaji Nuthalapadi's appointment as interim MD and CEO. Current MD and CEO P.N. Vasudevan will be relieved at the earliest.
- Skyways Air: Renews its global annual agreement with Qatar Airways Group, effective January 1, 2026.
- Prestige Estates: Plans to acquire a 100% stake in Allure Developers for Rs. 524 crore.
- SML Mahindra: Board meeting scheduled for November 13 to consider a rights issue.
- Asian Paints: Leo Puri will assume the position of Chairman from January 23, following the completion of R. Seshasayee's tenure.
Earnings Highlights
- Revenue grew 10.3% YoY to Rs. 806 crore vs Rs. 731 crore.
- EBITDA grew 38.5% YoY to Rs. 187 crore vs Rs. 135 crore.
- EBITDA margin improved to 23.2% vs 18.5% YoY.
- Net profit grew 13.6% YoY to Rs. 50 crore vs Rs. 44 crore.
- Revenue grew 25.9% YoY to Rs. 180 crore vs Rs. 143 crore.
- EBITDA loss narrowed to Rs. 5.3 crore vs Rs. 22.6 crore.
- Net profit stood at Rs. 5 crore against a loss of Rs. 17.2 crore YoY.
- Revenue grew 17% YoY to Rs. 5,734 crore vs Rs. 4,900 crore.
- EBITDA grew 2.8% YoY to Rs. 626 crore vs Rs. 609 crore.
- EBITDA margin declined to 10.9% vs 12.4% YoY.
- Net profit grew 3.9% YoY to Rs. 504 crore vs Rs. 485 crore.
- Revenue grew 14.5% YoY to Rs. 1,774 crore vs Rs. 1,549 crore.
- EBITDA grew 14.2% YoY to Rs. 287 crore vs Rs. 252 crore.
- EBITDA margin remained flat at 16.2% YoY.
- Net profit grew 28.4% YoY to Rs. 104 crore vs Rs. 81 crore.
- Revenue grew 15.6% YoY to Rs. 453 crore vs Rs. 392 crore.
- EBITDA grew 24.4% YoY to Rs. 56.5 crore vs Rs. 45.4 crore.
- EBITDA margin improved to 12.5% vs 11.6% YoY.
- Net profit increased to Rs. 22 crore vs Rs. 3.3 crore YoY.
- Announces an interim dividend of Rs. 2 per share.
- Revenue grew 23.3% YoY to Rs. 1,834 crore vs Rs. 1,487 crore.
- EBITDA grew 54.1% YoY to Rs. 484 crore vs Rs. 314 crore.
- EBITDA margin improved to 26.4% vs 21.1% YoY.
- Net profit grew 58.2% YoY to Rs. 291 crore vs Rs. 184 crore.
- Revenue grew 46.9% YoY to Rs. 1,824 crore vs Rs. 1,242 crore.
- EBITDA grew 82.7% YoY to Rs. 1,091 crore vs Rs. 597 crore.
- EBITDA margin improved to 59.8% vs 48.1% YoY.
- Net profit increased to Rs. 1,269 crore vs Rs. 581 crore YoY.
- Announces a second interim dividend of Rs. 14.4 per share.
- Revenue stood at Rs. 2,829 crore vs Rs. 1,197 crore YoY.
- EBITDA stood at Rs. 664 crore vs Rs. 250 crore YoY.
- EBITDA margin improved to 23.5% vs 20.9% YoY.
- Net profit increased to Rs. 262 crore vs Rs. 110 crore YoY.
- Revenue grew 15.3% YoY to Rs. 2,707 crore vs Rs. 2,347 crore.
- EBITDA grew 82.4% YoY to Rs. 128 crore vs Rs. 70.4 crore.
- EBITDA margin improved to 4.7% vs 3% YoY.
- Net profit grew 53.4% YoY to Rs. 52.6 crore vs Rs. 34.3 crore.
- Revenue stood at Rs. 417 crore vs Rs. 18.1 crore YoY.
- EBITDA stood at Rs. 85.9 crore vs Rs. 1 crore YoY.
- EBITDA margin improved to 20.6% vs 5.5% YoY.
- Net profit stood at Rs. 42.5 crore vs Rs. 4.2 crore YoY.
- Revenue grew 21.8% YoY to Rs. 1,265 crore vs Rs. 1,038 crore.
- EBITDA grew 75.9% YoY to Rs. 263 crore vs Rs. 149 crore.
- EBITDA margin improved to 20.8% vs 14.4% YoY.
- Net profit grew 19.1% YoY to Rs. 165 crore vs Rs. 139 crore.
- Revenue declined 14.2% YoY to Rs. 476.7 crore vs Rs. 555.6 crore.
- EBITDA declined 70.7% YoY to Rs. 35.5 crore vs Rs. 121 crore.
- EBITDA margin declined to 7.4% vs 21.8% YoY.
- Net profit declined 79.5% YoY to Rs. 15.2 crore vs Rs. 74.1 crore.
- Revenue grew 31.1% YoY to Rs. 190.9 crore vs Rs. 145.6 crore.
- EBITDA grew 37.5% YoY to Rs. 72.2 crore vs Rs. 52.5 crore.
- EBITDA margin improved to 37.8% vs 36.1% YoY.
- Net profit declined 5.8% YoY to Rs. 30.8 crore vs Rs. 32.7 crore.
- Revenue grew 44.1% YoY to Rs. 463.6 crore vs Rs. 321.7 crore.
- EBITDA stood at Rs. 23.6 crore against a loss of Rs. 56.2 crore YoY.
- EBITDA margin stood at 5.1% in Q2.
- Net loss narrowed to Rs. 17.2 crore vs Rs. 100 crore YoY.
- Revenue declined 56.7% YoY to Rs. 133 crore vs Rs. 307 crore.
- EBITDA declined 54.2% YoY to Rs. 31.4 crore vs Rs. 68.5 crore.
- EBITDA margin improved to 23.5% vs 22.3% YoY.
- Net profit declined 55.6% YoY to Rs. 21.8 crore vs Rs. 49.2 crore.
- Revenue declined 53.2% YoY to Rs. 152 crore vs Rs. 325 crore.
- EBITDA grew 91.4% YoY to Rs. 58 crore vs Rs. 30.3 crore.
- EBITDA margin improved to 38.2% vs 9.3% YoY.
- Net profit increased to Rs. 18.9 crore vs Rs. 2.8 crore YoY.
- Revenue grew 48.3% YoY to Rs. 1,272 crore vs Rs. 857 crore.
- EBITDA stood at Rs. 53.7 crore vs Rs. 17.1 crore YoY.
- EBITDA margin improved to 4.2% vs 2% YoY.
- Net profit stood at Rs. 13.9 crore vs Rs. 5.2 crore YoY.
- Revenue grew 23.5% YoY to Rs. 397.5 crore vs Rs. 321.9 crore.
- EBITDA grew 11.2% YoY to Rs. 84.4 crore vs Rs. 75.8 crore.
- EBITDA margin declined to 21.2% vs 23.6% YoY.
- Net profit grew 9.1% YoY to Rs. 65.9 crore vs Rs. 60.4 crore.
- Announces an interim dividend of Rs. 20 per share.
- Revenue grew 22.6% YoY to Rs. 5,486 crore vs Rs. 4,476 crore.
- EBITDA grew 34.4% YoY to Rs. 843 crore vs Rs. 627 crore.
- EBITDA margin improved to 15.4% vs 14% YoY.
- Net profit grew 99% YoY to Rs. 211 crore vs Rs. 106 crore.
- Revenue grew 35% YoY to Rs. 3,676 crore vs Rs. 2,715 crore.
- EBITDA grew 76% YoY to Rs. 1,566 crore vs Rs. 888 crore.
- EBITDA margin improved to 42.6% vs 32.7% YoY.
- Net profit grew 64% YoY to Rs. 1,127 crore vs Rs. 689 crore.
- Revenue declined 7% YoY to Rs. 311 crore vs Rs. 335 crore.
- EBITDA grew 90% YoY to Rs. 24.7 crore vs Rs. 13 crore.
- EBITDA margin improved to 7.9% vs 3.9% YoY.
- Net profit stood at Rs. 13 crore vs Rs. 3.5 crore YoY.
- Revenue grew 8% QoQ to Rs. 65,436 crore vs Rs. 60,794 crore.
- EBITDA grew 14% QoQ to Rs. 10,533 crore vs Rs. 9,264 crore.
- EBITDA margin improved to 16.1% vs 15.2% QoQ.
- Net profit grew 58% QoQ to Rs. 3,666 crore vs Rs. 2,318 crore.
- Revenue grew 44% YoY to Rs. 2,917 crore vs Rs. 2,019 crore.
- EBITDA grew 55.3% YoY to Rs. 736 crore vs Rs. 474 crore.
- EBITDA margin improved to 25.2% vs 23.5% YoY.
- Net profit grew 58% YoY to Rs. 494 crore vs Rs. 314 crore.
- Revenue declined 29% YoY to Rs. 872 crore vs Rs. 1,223 crore.
- EBITDA declined 58% YoY to Rs. 230 crore vs Rs. 544 crore.
- EBITDA margin declined to 26.4% vs 44.5% YoY.
- Net profit declined 50% YoY to Rs. 193 crore vs Rs. 387 crore.
- Revenue grew 65% YoY to Rs. 2,269.3 crore vs Rs. 1,375.8 crore.
- EBITDA stood at Rs. 311.1 crore vs Rs. 145 crore YoY.
- EBITDA margin improved to 13.7% vs 10.5% YoY.
- Net profit grew 68% YoY to Rs. 273 crore vs Rs. 162 crore.
- Revenue grew 33% YoY to Rs. 2,448 crore vs Rs. 1,845 crore.
- EBITDA grew 1% YoY to Rs. 143 crore vs Rs. 141 crore.
- EBITDA margin declined to 5.8% vs 7.6% YoY.
- Net profit grew 3% YoY to Rs. 77 crore vs Rs. 74 crore.
- Revenue grew 21% YoY to Rs. 1,135 crore vs Rs. 941 crore.
- EBITDA grew 39% YoY to Rs. 138.5 crore vs Rs. 100 crore.
- EBITDA margin improved to 12.2% vs 10.6% YoY.
- Net profit grew 5% YoY to Rs. 53.4 crore vs Rs. 50.9 crore.
- Revenue grew 8% YoY to Rs. 4,177 crore vs Rs. 3,877 crore.
- EBITDA declined 29% YoY to Rs. 381 crore vs Rs. 537 crore.
- EBITDA margin declined to 9.1% vs 13.9% YoY.
- Reported a net loss of Rs. 122 crore against a profit of Rs. 77 crore YoY.